Document Detail

Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome.
MedLine Citation:
PMID:  22204899     Owner:  NLM     Status:  Publisher    
Multidisciplinary approach and patient counselling have been the key points in the improvement of the management of pregnancy in women with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Most of these women can have successful pregnancy when thoroughly informed and instructed on several different issues. Disease activity should be in stable remission prior to pregnancy in order to reduce the chance for flare during pregnancy. To this purpose, medications must be modulated: "safe" drugs should be continued throughout pregnancy, embryotoxic/foetotoxic drugs should be withdrawn timely, and beneficial drugs such as low dose aspirin and heparin should be added for prophylaxis of maternal and foetal outcome, especially in the presence of antiphospholipid antibodies. The safety profile of anti-rheumatic drugs during pregnancy and breastfeeding should be kept constantly updated, as new data from inadvertent exposure accumulates and new drugs (especially biological agents) are available. Patients may carry autoantibodies that can negatively affect the baby, being neonatal lupus the prototypical case of passively acquired autoimmunity. Research has been greatly active in this field and more information on risk stratification and management are now available for counselling. The effect of both autoantibodies and drug exposure has been evaluated in the offspring: some concerns about learning disabilities have been raised, but these are treatable conditions that are likely to be overcome. To counsel a woman with SLE/APS during childbearing age means also to deal with contraception. Despite the "preferred choice" - combined oral contraceptive - may not be suitable for most of the patients, other options are available and should be offered and discussed with the patient. Fertility is not generally affected in SLE/APS patients, but those cases who require assisted reproduction techniques should be carefully evaluated and managed.
Laura Andreoli; Micaela Fredi; Cecilia Nalli; Rossella Reggia; Andrea Lojacono; Mario Motta; Angela Tincani
Related Documents :
19265049 - Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the h...
14645169 - Thromboelastography, whole-blood haemostasis and recurrent miscarriage.
7471449 - Concerning a new pathogenetic hypothesis of the e.p.h. gestosis (note i).
14580379 - Augmented pla2 activity in pre-eclamptic decidual tissue--a key player in the pathophys...
15121029 - Do pregnancy complications and cvd share common antecedents?
7280909 - Amyloidosis and pregnancy. a case report.
17505669 - Detection of parvovirus b19 infection in formalin-fixed and paraffin-embedded placenta ...
2866859 - Cardiovascular and respiratory agents during pregnancy: implications for fetal developm...
23700889 - Cervical incompetence associated with congenital uterine malformations.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-26
Journal Detail:
Title:  Journal of autoimmunity     Volume:  -     ISSN:  1095-9157     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8812164     Medline TA:  J Autoimmun     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Rheumatology and Clinical Immunology, Spedali Civili, University of Brescia, Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Changes in intolerance of uncertainty during cognitive behavior group therapy for social phobia.
Next Document:  Sex differences and genomics in autoimmune diseases.